ANLON HEALTHCARE LIMITED (AHCL) Share Price Falls 9.38% Amid Market Volatility
- July 30, 2026
- Posted by: Harsh Piplani
- Category: News
ANLON HEALTHCARE LIMITED Share Price falls 9.38% to Rs 14.4, with a market cap of Rs 844.58 crore.
ANLON HEALTHCARE LIMITED Share Price experienced a significant decline today, falling by 9.38% to close at Rs 14.4. This drop places the company’s market capitalisation at Rs 844.58 crore, categorising it within the Micro Cap segment. The share price opened at Rs 15.89, matching the previous close, but failed to maintain its value throughout the trading session. The day’s low was recorded at Rs 14.21, indicating a volatile trading day for the stock.
< The absence of a specific company-related catalyst suggests that broader market conditions or sector-specific trends may have influenced today's trading activity. Investors are keenly observing the stock's performance, given its significant movement today.
ANLON HEALTHCARE LIMITED (AHCL) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 14.4 |
| Previous Close | Rs 15.89 |
| Today's Change | Rs -1.49 (-9.38%) |
| Day Open | Rs 15.89 |
| Day High | Rs 15.89 |
| Day Low | Rs 14.21 |
| Current Volume (BSE) | 4,10,964 |
| BSE Traded Volume | 4,10,964 |
| NSE Traded Volume | 60,16,974 |
| Combined NSE + BSE Volume | 64,27,938 |
| Turnover | Rs 0.59 crore |
| Market Capitalisation | Rs 844.58 crore |
| Market Cap Category | Micro Cap |
ANLON HEALTHCARE LIMITED (AHCL) traded at Rs 14.4. versus the previous close of Rs 15.89, a fall of 9.38%. The stock opened at Rs 15.89, reached Rs 15.89, touched Rs 14.21. Reported volume was 4,10,964.
ANLON HEALTHCARE LIMITED (AHCL) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 844.58 crore |
| P/E Ratio | 30.37x |
| P/B Ratio | 3.21x |
| ROE | -6.93% |
| ROCE | 6.42% |
| EPS | Rs 0.52 |
| Dividend Yield | 0% |
ANLON HEALTHCARE LIMITED was valued at a P/E ratio of 30.37x, a P/B ratio of 3.21x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.
Profitability and capital efficiency were represented by ROE of -6.93% and ROCE of 6.42%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.
Per-share and shareholder-return metrics included EPS of Rs 0.52, dividend yield of 0%. Dividend yield is a current or historical ratio and does not guarantee future distributions.
ANLON HEALTHCARE LIMITED’s market capitalisation of Rs 844.58 crore places it in the Micro Cap category, which often experiences higher volatility. The company’s P/E ratio is 30.37, which is above the industry median of 26.56 but below the industry average of 80.39. This suggests that the stock is priced higher than the median but remains relatively inexpensive compared to the average.
The P/B ratio of 3.21 is higher than the industry median of 1.81, indicating a premium valuation relative to book value. The company’s ROE is -6.93%, which is below the industry median of 9.91%, reflecting challenges in generating returns on equity. The ROCE stands at 6.42%, also below the industry median of 12.96%, highlighting potential inefficiencies in capital utilisation.
The EPS of Rs 0.52 indicates the earnings attributable to each share, while the absence of a dividend yield suggests that the company is not currently returning profits to shareholders through dividends. These fundamentals provide a mixed picture, with valuation ratios suggesting a premium, while profitability metrics indicate room for improvement.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 30.37x |
| Benchmark Median P/E | 26.56x |
| Benchmark Average P/E | 80.39x |
| Benchmark P/E Range | 3.47x to 3,385.56x |
| Company P/B Ratio | 3.21x |
| Benchmark Median P/B | 1.81x |
| Company ROE | -6.93% |
| Benchmark Median ROE | 9.91% |
| Company ROCE | 6.42% |
| Benchmark Median ROCE | 12.96% |
| Company Market Capitalisation | Rs 844.58 crore |
| Benchmark Median Market Cap | Rs 146.72 crore |
ANLON HEALTHCARE LIMITED (AHCL) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
ANLON HEALTHCARE LIMITED (AHCL) has a P/E ratio of 30.37x, which is above the benchmark median of 26.56x, a difference of +14.34%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
ANLON HEALTHCARE LIMITED (AHCL) has a ROE of -6.93%, which is below the benchmark median of 9.91%, a difference of -169.93%. ANLON HEALTHCARE LIMITED (AHCL) has a ROCE of 6.42%, which is below the benchmark median of 12.96%, a difference of -50.46%.
Track today’s top decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
ANLON HEALTHCARE LIMITED operates within the Healthcare sector, specifically in the Pharmaceuticals & Drugs industry. The sector benchmark includes 137 companies, providing a comprehensive view of industry performance. The company’s P/E ratio of 30.37 is above the industry median of 26.56, indicating a relatively higher valuation compared to its peers.
The industry average P/B ratio is 2.49, with ANLON HEALTHCARE LIMITED’s P/B ratio of 3.21 suggesting a premium valuation. The company’s ROE of -6.93% is significantly below the industry median of 9.91%, highlighting challenges in profitability. Similarly, the ROCE of 6.42% is below the industry median of 12.96%, indicating potential inefficiencies in capital utilisation.
The sector’s market capitalisation ranges from Rs 6.44 crore to Rs 2,856.59 crore, with ANLON HEALTHCARE LIMITED’s market cap of Rs 844.58 crore placing it in the lower half of the spectrum. This positioning within the sector reflects the company’s smaller size relative to its peers.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Dishman Carbogen Amcis Ltd. | DCAL | 2,856.59 | 30.28 | 0.44 | -2.89 | -0.26 |
| Kwality Pharmaceuticals Ltd. | KPL | 2,686.76 | 40.11 | 8.17 | 28.21 | 26.35 |
| Hikal Ltd. | HIKAL | 2,676.24 | 0 | 2.27 | 15.22 | 16.15 |
| Panacea Biotec Ltd. | PANACEABIO | 2,540.37 | 0 | 3.11 | 0 | 5.36 |
| Solara Active Pharma Sciences Ltd. | SOLARA | 2,446.19 | 0 | 1.91 | 17.23 | 15.34 |
ANLON HEALTHCARE LIMITED (AHCL) has a P/E ratio of 30.37x compared with the displayed peer median of 0x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -6.93% compares with a peer median of 15.22% across the companies shown in the table. ROCE stood at 6.42% versus the displayed peer median of 15.34%, providing a capital-efficiency comparison. ANLON HEALTHCARE LIMITED (AHCL) has a market capitalisation of Rs 844.58 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
In comparison to its peers, ANLON HEALTHCARE LIMITED’s P/E ratio of 30.37 is similar to Dishman Carbogen Amcis Ltd. (30.28) but lower than Kwality Pharmaceuticals Ltd. (40.11). The company’s P/B ratio of 3.21 is higher than Hikal Ltd. (2.27) but lower than Beta Drugs Ltd. (9.44).
The ROE of -6.93% is below most peers, with Kwality Pharmaceuticals Ltd. achieving 28.21% and Hester Biosciences Ltd. at 16.17%. The ROCE of 6.42% is also lower than peers like Kwality Pharmaceuticals Ltd. (26.35%) and Beta Drugs Ltd. (22.17%). These comparisons highlight ANLON HEALTHCARE LIMITED’s relative weaknesses in profitability metrics.
Why Investors Are Watching ANLON HEALTHCARE LIMITED
Investors are closely monitoring ANLON HEALTHCARE LIMITED due to its significant price movement and market positioning. The company’s performance today has drawn attention, and several factors are under scrutiny:
- Significant 9.38% price decline in the Micro Cap category.
- Neutral RSI indicating balanced momentum.
- Premium valuation with challenges in profitability.
- Positioning within the Healthcare sector and Pharmaceuticals & Drugs industry.
Investors should continue to watch for any changes in market conditions or company-specific developments that could impact ANLON HEALTHCARE LIMITED’s share price. Monitoring sector trends and peer performance will also provide valuable insights.
About ANLON HEALTHCARE LIMITED
ANLON HEALTHCARE LIMITED operates in the Healthcare sector, focusing on the Pharmaceuticals & Drugs industry. The company engages in the development, manufacturing, and marketing of pharmaceutical products. Its product portfolio includes a range of drugs catering to various therapeutic areas, contributing to its revenue streams.
As a player in the Pharmaceuticals & Drugs industry, ANLON HEALTHCARE LIMITED competes with other companies in the sector, striving to enhance its market position and expand its product offerings. The company’s strategic initiatives and market presence are key factors influencing its performance and growth prospects.
Track ANLON HEALTHCARE LIMITED Share Price on Univest
Use ANLON HEALTHCARE LIMITED (AHCL) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners lists and related market analysis.
Investors can track ANLON HEALTHCARE LIMITED Share Price on Univest for real-time updates and insights. Univest provides access to live share prices, technical indicators, fundamental ratios, shareholding patterns, and market insights. Stay informed about ANLON HEALTHCARE LIMITED’s performance and market trends with Univest’s comprehensive tools and resources.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What caused ANLON HEALTHCARE LIMITED's share price to fall today?
Ans. ANLON HEALTHCARE LIMITED's share price fell by 9.38% today, but the data does not specify a company-specific catalyst. Broader market conditions or sector trends may have influenced the decline. The stock moved -9.38% during the session.
How does ANLON HEALTHCARE LIMITED's P/E ratio compare to the industry?
Ans. ANLON HEALTHCARE LIMITED's P/E ratio of 30.37 is above the industry median of 26.56, indicating a higher valuation compared to the median but lower than the industry average of 80.39.
What is the current market capitalisation of ANLON HEALTHCARE LIMITED?
Ans. The current market capitalisation of ANLON HEALTHCARE LIMITED is Rs 844.58 crore, placing it in the Micro Cap category within the Healthcare sector. The company operates in the Healthcare sector.
How does ANLON HEALTHCARE LIMITED's ROE compare to its peers?
Ans. ANLON HEALTHCARE LIMITED's ROE of -6.93% is below most peers, with companies like Kwality Pharmaceuticals Ltd. achieving 28.21% and Hester Biosciences Ltd. at 16.17%. ROE stands at -6.93%. ROCE stands at 6.42%.
How does ANLON HEALTHCARE LIMITED's P/B ratio compare to the industry?
Ans. ANLON HEALTHCARE LIMITED's P/B ratio of 3.21 is higher than the industry median of 1.81, suggesting a premium valuation relative to book value. The company trades at a P/E ratio of 30.37x.
What sector does ANLON HEALTHCARE LIMITED operate in?
Ans. ANLON HEALTHCARE LIMITED operates in the Healthcare sector, specifically within the Pharmaceuticals & Drugs industry, focusing on the development and marketing of pharmaceutical products. The stock belongs to the Healthcare sector.
